Pyxis Oncology Inc是一家肿瘤学公司。该公司专注于开发下一代疗法，以针对难以治疗的癌症并改善患者的生活质量。该公司利用其完全整合的研究、开发和商业能力来建立多元化的下一代治疗产品组合。该公司的治疗候选药物旨在直接杀死肿瘤细胞并解决癌症造成 ...

Jesse Calis spent a month with the Blackmagic PYXIS 12K cinema camera. His verdict: “If you are a serious filmmaker… this camera is really for you.” And how. Watch his full review of the Blackmagic ...

The initial funding round underscores growing investor confidence in decarbonising regional port and shipping operations. SINGAPORE - Media OutReach Newswire - 22 December 2025 - Pyxis, a leading ...

Pyxis secured S$13 million in the first close of its S$18 million growth funding round, reflecting strong investor confidence in its vessel technology, commercial traction, and regional growth ...

Pyxis Oncology Inc. (NASDAQ: PYXS) on Thursday released preliminary data from its ongoing Phase 1 studies of micvotabart pelidotin (MICVO) for recurrent/metastatic head and neck squamous cell ...

BOSTON, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced positive ...

本期推荐一款名为Pyxis的跨平台软件，其致力于解决离子淌度质谱成像（IM-MSI）数据处理中因缺乏全流程分析工具而阻碍技术应用的瓶颈问题。研究团队通过开发集成预处理、可视化、数据挖掘与代谢物鉴定功能的计算平台，成功实现对小鼠肾脏组织和THP-1单细胞 ...

Investing.com -- Pyxis Oncology Inc (NASDAQ:PYXS) stock tumbled 49.9% in premarket trading Thursday after investors expressed disappointment with preliminary data from the company’s experimental ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...